tirzepatide bimagrumab Tirzepatide‐induced body composition changes: Implications from the SURPASS‐3 MRI substudy 𝗕𝗶𝗺𝗮𝗴𝗿𝘂𝗺𝗮𝗯: 𝗣𝗿𝗲𝘀𝗲𝗿𝘃𝗶𝗻𝗴 𝗠𝘂𝘀𝗰𝗹𝗲 𝗠𝗮𝘀𝘀 𝗗𝘂𝗿𝗶𝗻𝗴

The RSSDI Treatment Ladder, In Plain Language Step one: lifestyle change plus metformin for most newly diagnosed adults [1] Step two: if HbA1c is still above target after about three months, a second medicine is added rather than delayed Step three: the choice of that second medicine depends on your risk profile heart disease, kidney disease, or obesity push the decision towards a GLP-1 receptor agonist or an SGLT2 inhibitor [2] Step four: insulin is brought in when oral and injectable non-insulin options are not enough, and it can later be reduced if a GLP-1 drug is added Who Is Most Likely To Benefit From Adding A GLP-1

First Week Expectations: What Changes You Might Notice During the opening seven days, you may experience mild nausea, slight stomach discomfort, or a gentle sense of fullness that appears sooner than usual at meals

Among patients with mutations in exons 6 and 7, 41% and 56% of them displayed epilepsy, respectively

Archived from the original (PDF) on 16 October 2013